About PreOmics
PreOmics is a company based in Munchen (Germany) founded in 2014 by Nils Kulak. PreOmics has raised $19.14 million across 7 funding rounds from investors including Bruker, EIT Health and European Union. The company has 22 employees as of December 31, 2020. PreOmics offers products and services including iST Kit, BeatBox, APP96, ENRICH-iST, and PreON. PreOmics operates in a competitive market with competitors including PrognomiQ, LenioBio, Vivostat, Expedeon and List Biological Laboratories, among others.
- Headquarter Munchen, Germany
- Employees 22 as on 31 Dec, 2020
- Founders Nils Kulak
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Preomics Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.14 M (USD)
in 7 rounds
-
Latest Funding Round
$15.41 M (USD), Series B
Jan 18, 2022
-
Investors
Bruker
& 6 more
-
Employee Count
22
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PreOmics
PreOmics offers a comprehensive portfolio of products and services, including iST Kit, BeatBox, APP96, ENRICH-iST, and PreON.
Kit for preparing protein samples for mass spectrometry analysis
Device for fast and reproducible tissue and cell homogenization
System for high-throughput automated sample preparation
Kit for enriching low-abundance proteins in plasma and serum
Fully automated system for iST kit workflows
People of PreOmics
Unlock access to complete
Funding Insights of PreOmics
PreOmics has successfully raised a total of $19.14M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $15.41 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PreOmics
PreOmics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Bruker, EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Early-stage tech & life sciences focused VC firm investing in geographies such as Europe
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked |
Investor details for PreOmics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PreOmics
Investment portfolio details for PreOmics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PreOmics
Detailed financials for PreOmics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Preomics Comparisons
Peer comparison for PreOmics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PreOmics
PreOmics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, LenioBio, Vivostat, Expedeon and List Biological Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| Locked | Locked | Locked |
Kits for cell-free eukaryotic protein expression are provided.
|
|
| Locked | Locked | Locked |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| Locked | Locked | Locked |
Reagents and kits for protein-based research are developed and supplied.
|
|
| Locked | Locked | Locked |
Specializes in the production of research reagents
|
Detailed competitors of PreOmics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Preomics
Complete news archive for PreOmics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PreOmics
PreOmics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
PreOmics is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Nils Kulak is the current CEO of PreOmics. They have also founded this company.
PreOmics is a funded company, having raised a total of $19.14M across 7 funding rounds to date.
As of Dec 31, 2020, the latest employee count at PreOmics is 22.
PreOmics was founded in 2014 in Munich, Germany, and operates within the proteomics research sector. Sample preparation kits for reproducible peptide mixtures from various starting materials are manufactured, along with accessories for proteomics workflows. A nano-flow automated peptide pre-fractionation device named SPIDER is currently under development as the companys next innovation.
PreOmics offers iST Kit, BeatBox, APP96, ENRICH-iST, and PreON.
PreOmics has 7 investors. Key investors include Bruker, EIT Health, European Union, EIC Fund, and Think.Health.